OncoMed Pharmaceuticals Inc (OMED.O) Company Profile
OncoMed Pharmaceuticals, Inc. (OncoMed) incorporated on July 19, 2004, is a clinical development-stage biopharmaceutical company. The Company focuses on discovering and developing monoclonal antibody therapeutics targeting cancer stem cells (CSCs). It utilizes its technologies to identify, isolate and evaluate CSCs; identify and/or validate multiple potential targets and pathways critical to CSC self-renewal and differentiation; and develop targeted antibody and other protein-based therapeutics that are designed to modulate these CSC targets and inhibit the growth of CSCs. The Company’s anti-cancer therapeutics include anti-DLL4 (demcizumab, OMP-21M18), Anti-DLL4/Anti-VEGF Bispecific, and Anti-Notch2/3 (OMP-59R5), Anti-Notch1 (OMP-52M51, Anti-Fzd7, Fzd8-Fc, RSPO-LGR.
Anti-DLL4 (demcizumab, OMP-21M18) is a humanized monoclonal antibody that inhibits Delta Like Ligand 4 (DLL4) in the Notch signaling pathway. The Company has completed a single-agent Phase Ia trial in advanced solid tumor patients. The Company focuses on conducting two Phase Ib combination trials of demcizumab. Anti-DLL4/anti-VEGF bispecific is a monoclonal antibody that targets and inhibits both DLL4 and vascular endothelial growth factor ( VEGF). VEGF is the target of Avastin. Anti-Notch2/3 (OMP-59R5) is a human monoclonal antibody that targets the Notch2 and Notch3 receptors.
Anti-Notch1 OMP-52M51 is a humanized monoclonal antibody targeted to the Notch1 receptor. Anti-Fzd7 OMP-18R5 is a human monoclonal antibody identified by screening against the Frizzled7 receptor (Fzd7) that binds a conserved epitope on five Frizzled receptors and inhibits Wnt signaling. OMP-18R5 is in a Phase I single-agent trial in advanced solid tumor patients. Fzd8-Fc OMP-54F28 is a fusion protein based on a truncated form of the Frizzled8 receptor ( Fzd8). RSPO-LGR ligands signal through the LGR receptor family.
The Company utilizes several robust technologies for the discovery and optimization of its antibody and protein-! based therapeutics, including multiple proprietary technologies. Its antibody technologies include Mammalian Display Technology, Bispecific Antibody Technology, Hybridoma Technology. Mammalian Display Technology utilizes flow cytometry to isolate mammalian cells expressing antibodies on the cell surface with desired characteristics from large libraries of candidate antibodies. Bispecific Antibody Technology is used to generate its anti-DLL4/anti-VEGF antibody. Hybridoma Technology is used for isolating antibodies from mice, including multiplex single-cell screening techniques.
News about OMED
Gen Z: New Gender Norms, Fake News, Frugality And The Rise Of Retail's Next Power Generation
&l;img class=&q;dam-image getty size-large wp-image-1051329212&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/1051329212/960x0.jpg?fit=scale&q; data-height=&q;640&q; data-width=&q;960&q;&g;&l;span&g;One constant for leaders in the &l;...Read More>>>
Four Strategic Mistakes Distanced Sears From Customers And Employees
&l;p&g;&l;img class=&q;dam-image getty size-large wp-image-1053277910&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/1053277910/960x0.jpg?fit=scale&q; data-height=&q;640&q; data-width=&q;960&q;&g; (Photo by Eduardo Munoz Alvarez/VIEWp...Read More>>>
Guess Who's Profiting From GE's Troubles?
One person's challenge is another's opportunity, and there are very few CEOs as bold and decisive in taking advantage of a chance to enhance value for shareholders as Emerson Electric's (NYSE:EMR) David Farr. Although the terms of Emerson's deal to b...Read More>>>
3 Top Artificial Intelligence Stocks to Watch in October
For technology investors, it's easy to miss the forest for the trees in the elusive hunt for "the next big thing." That said, whether you feel the next breakout technology is autonomous cars, the Internet of Things, chatbots, or machine learning, art...Read More>>>
A top FTSE 100 income stock, and a cheap hidden dividend gem, that could still spike in October
&l;p&g;&l;img class=&q;dam-image getty size-large wp-image-1051294902&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/1051294902/960x0.jpg?fit=scale&q; data-height=&q;635&q; data-width=&q;960&q;&g; Photo: Getty Images.As we step into t...Read More>>>